JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M000499200 on March 21, 2000

J. Biol. Chem., Vol. 275, Issue 22, 17058-17063, June 2, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/22/17058    most recent
M000499200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamai, E.
Right arrow Articles by Tsuchiya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamai, E.
Right arrow Articles by Tsuchiya, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mutations That Increase the Activity of the Promoter of the Escherichia coli Melibiose Operon Improve the Binding of MelR, a Transcription Activator Triggered by Melibiose*

Eiji TamaiDagger , Tamara A. Belyaeva§, Stephen J. W. Busby§, and Tomofusa TsuchiyaDagger

From the Dagger  Department of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, 700-8530 Japan and the § School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom

Received for publication, January 22, 2000, and in revised form, March 10, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

MelR is an Escherichia coli transcription factor that activates expression of the melAB operon in response to the presence of melibiose in the environment. MelR stimulates transcription initiation at the melAB promoter by binding to four sites centered at positions -120.5, -100.5, -62.5, and -42.5 upstream of the transcript start point. In a previous study, we described a spontaneous mutant that exhibited increased melAB expression. Sequence analysis showed that this mutant carries five consecutive base changes at positions -49, -50, -51, -52, and -53 upstream of the melAB transcript start. Here we show that these changes improve MelR binding to the target site centered at position -42.5 at the melAB promoter and that this improvement is responsible for increased promoter activity. Thus, the activity of the melAB promoter is fixed by the occupation by MelR of a DNA site that overlaps the -35 hexamer: MelR appears to be a typical class II-type transcription activator.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Melibiose metabolism by Escherichia coli is contingent on expression of the melA and melB genes, that are cotranscribed from a single promoter in response to the presence of melibiose in the growth medium: melA encodes an alpha -galactosidase, whereas melB encodes a melibiose transporter (1-5). An unusual feature of E. coli K12 strains is that they are able to metabolize melibiose at 30 °C, but they become progressively less able to metabolize melibiose at temperatures above 37 °C, due to thermal lability of the melB melibiose transporter (6). In recent work (7), we have studied the W3133-2 mutant that is able to grow at higher temperatures with melibiose as the sole carbon source. Although we had expected that the melB gene in this mutant would be altered in some way, we found that the W3133-2 mutant carried five consecutive base changes in the melAB promoter. We showed that these changes led to an increase in expression of the melAB operon at all temperatures and that this increase, apparently, could compensate for the thermolability of the melB melibiose transporter (7). The principal objective of the work presented here has been to understand the effects of the base changes in the W3133-2 mutant.

Transcription initiation at the melAB promoter is totally dependent on MelR, a melibiose-triggered transcription activator (8). MelR is encoded by the melR gene, which is located immediately upstream of the melA gene, and transcribed from a promoter that is divergent from the melAB promoter (the transcription start points of the melAB and melR promoters are 237 bases apart; see Fig. 1) (9). MelR is a member of the AraC family of transcription factors and binds to 18-base pair target sequences (10). At the melAB promoter, MelR binds to four such target sequences: site 1', site 1, site 2, and site 2' centered at positions -120.5, -100.5, -62.5, and -42.5, respectively, upstream of the melAB transcript start point (Fig. 1). Recent studies (11) have shown that the occupation of site 2' by MelR is the most crucial for the activation of the melAB promoter, but that, of the four target sites, site 2' binds MelR most weakly. We noted that the base changes in the melAB promoter in the W3133-2 mutant changed the DNA sequence of MelR binding site 2' such that it corresponded better to the tighter binding site 1', site 1, and site 2. This suggested that the increased melAB expression in the W3133-2 mutant could be due to better binding of MelR to site 2'. In the work reported here, we prove that this is indeed the case, by studying the binding of purified MelR and purified RNA polymerase holoenzyme (RNAP)1 to DNA fragments carrying the melAB promoter from both the wild type and W3133-2 mutant strain

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Subcloning the mel Operon Regulatory Region-- Plasmids pBM3133, carrying the entire wild type mel operon, and pBM3133-2, carrying the mel operon from the W3133-2 mutant, were described in our previous study (7). EcoRI-HindIII fragments, carrying the wild type or mutant mel operon regulatory region, were derived using polymerase chain reaction (PCR) using pBM3133 or pBM3133-2 as templates. The KK81 fragment, carrying an EcoRI site at position -312 with respect to the melAB transcript start, and a HindIII site at +36 was generated using the primers 5'-GCAGAATTCCGGGCTGCGGGT-3' and 5'-GCAAAGCTTGGATGCAGGTCGACGGATCTC-3' (see Fig. 1). The shorter JK14 fragment, with an EcoRI site at position -94 with respect to the melAB transcript start, and a HindIII site at +36, was made with the primers 5'-GCAGAATTCGATTTACTGCTGCTTCACG-3' and 5'-GCAAAGCTTGGATGCAGGTCGACGGATCTC-3' (see Fig. 1). PCR products carrying wild type or W3133-2 mutant sequences were restricted with EcoRI and HindIII and cloned either into plasmid vectors pSR (12) or pRW50 (13).

In Vivo Expression Assays-- The KK81 or JK14 EcoRI-HindIII fragments containing the wild type or mutant melAB promoters were cloned into pRW50, a low copy number lac expression vector (13), to generate pmelAB::lac fusions. Recombinant plasmids were propagated in strain WAM131 (11), an mel+ strain derived from GM-1 (14). beta -Galactosidase levels in these cells were measured using the method of Miller (15): cells were grown in media either with or without melibiose exactly as in our previous work (5).

Overexpression and Purification of His-tagged MelR-- In the histidine-tagged variant used here (MelRH), the carboxyl terminus of the MelR is extended by 7 amino acid residues, including 6 tandem histidines; the full sequence of this extension is (in single-letter code) IHHHHHH. To construct modified melR encoding the MelRH, we started with plasmid pBM3133 (7), in which the melibiose operon was cloned into the EcoRI site of pBR322. To insert a unique NdeI site at the initiation codon site of the melR gene and to remove the termination codon of melR, we used PCR mutagenesis using the primer melR(N-NdeI) (5'-ACATATGAATACAGATACGTTTATG-3') and melR(C) (5'-GCCGGGAAACGTCTGGCG-3'). The amplified DNA fragment was cloned into the EcoRV site of plasmid pBF4-11,2 which possesses a DNA sequence encoding 6 tandem histidines after the EcoRV site in pBluescript II SK(+). In the final step, an NdeI-BamHI fragment from the resulting plasmid was ligated to pET30a, a T7 expression vector obtained from Novagen, and digested with NdeI and BamHI. This generated plasmid pETRH, in which the encoded protein acquired the extension of 7 amino acid residues noted above. The construction was organized such that overexpressed product was initiated at the melR AUG initiation codon. A control plasmid, pETR, carrying authentic melR, was constructed using a similar strategy with melR(BamHI) (5'-TGGATCCTTAGCCGGGAAACGTCTG-3') as a PCR primer and pBluescript II SK(+) as a vector instead of melR(C) and pBF4-11, respectively. BL21(DE3) cells (from Novagen) harboring pETRH were used to overexpress His-tagged MelR protein. Cells from an overnight culture were diluted 50-fold into fresh M9 medium supplemented with 0.4% glucose, 0.2% casamino acid, and 60 mg/liter of kanamycin (200 ml), and grown at 37 °C for 3-4 h. After the optical density at 650 nm reached 0.8, addition of 1 mM isopropyl beta -D-thiogalactopyranoside allowed induction of MelRH during the following 3- to 4-h incubation. All subsequent work was done at 4 °C. After cells were harvested by centrifugation, and they were resuspended 10 ml of sonication buffer (100 mM potassium phosphate, pH 8.3, 200 mM KCl, 10% glycerol, 10 mM 2-mercaptoethanol, 1 mM EDTA) and subjected to lysis by ultrasonication (15 s × 12 times with 10-s intervals). After centrifugation at 22,500 × g for 20 min, inclusion body was resuspended in the same volume of the sonication buffer containing 4% Triton X-100 and recentrifuged at 22,500 × g for 20 min. The inclusion body was washed twice with the sonication buffer, and finally the inclusion body was solubilized in 10 ml of solubilization buffer (100 mM potassium phosphate, 200 mM KCl, 6 M guanidine-HCl, 10% glycerol, 1 mM 2-mercaptoethanol, 1 mM EDTA, pH 8.3). After centrifugation at 22,500 × g for 20 min, the supernatant fraction was kept at -20 °C until use.

For protein purification, we used 0.5-ml bed-volume amounts of Ni2+-agarose (Qiagen). The resin equilibrated with the solubilization buffer was added to 9.5 ml of the solubilized protein and kept for 30 min with gentle shaking to allow for binding of MelRH. The mixture was then placed in a column, unbound material was collected by gravity elution, and the column was washed with 10 ml of the solubilization buffer (pH 8.0). After nonspecifically bound material had been removed, MelRH was eluted with the solubilization buffer (pH 6.3). The eluted protein was dialyzed against a 50-fold volume of dialysis buffer (100 mM potassium phosphate, pH 7.4, 10% glycerol, 50 mM KCl, 10 mM 2-mercaptoethanol, 1 mM EDTA) four times. The dialyzed protein was concentrated by using Microcon 10 or Centricon 10 (Amicon). The purified protein was stored at -70 °C until use.

In Vitro Transcription Assays-- To measure in vitro transcription initiation, we used the pSR plasmid vector (12), which carries the bacteriophage lambda  oop transcription terminator just downstream of the EcoRI and HindIII cloning sites. Transcription experiments were performed using the protocols described by Kolb et al. (12). The KK81 or JK14 EcoRI-HindIII fragments containing the wild type or mutant melAB promoters were cloned into pSR such that transcripts initiating at the melAB promoter would run to the lambda  oop terminator. The resulting recombinants were purified by cesium chloride centrifugation and used as template for RNA synthesis. The preincubation mixtures contained 10 nM supercoiled plasmid DNA template in 20 mM Tris-HCl, pH 8.0, 5% glycerol, 100 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 1 mM dithiothreitol, and 50 µg/ml bovine serum albumin. Up to 1500 nM MelR and 10 mM melibiose (as appropriate) were added and incubated for 10 min at 37 °C. The incubation was continued with the addition of 20 nM purified RNAP (supplied by Amersham Pharmacia Biotech) for a further 5 min, prior to the addition of 200 µM ATP, CTP, and GTP, 10 µM alpha -32P-labeled UTP, and 100 µg/ml heparin. After an additional 5-min incubation, 32P-labeled RNA was analyzed on calibrated polyacrylamide sequencing gels. Transcription initiation at the melAB promoter gives rise to an easily detectable discrete transcript that terminates at the oop terminator, with the control RNA I from the pSR ColE1 origin acting as an internal control. Transcripts were quantified with the aid of a PhosphorImager (Molecular Dynamics, Inc.).

Gel Retardation Assays-- Starting with plasmid pBM3133 or pBM3133-2 as templates, PCR was used to amplify DNA fragments covering MelR binding sites 1', 1, 2, and 2' (ET1) from the wild type melAB promoter or the W3133-2 mutant. To do this, we used the -160 primer (5'-CGAGGGGACTCTCCGAGTATC-3') together with the -10 primer (5'-TAACTTCATCATGGCAGGCGA-3') shown schematically in Fig. 1. Before the PCR reaction, the -160 primer was end-labeled with 32P using T4 polynucleotide kinase. The labeled PCR product was used as a probe in gel retardation assays. Incubation mixtures contained 32P-labeled DNA probe and purified His-tagged MelR in 50 mM Tris-HCl, pH 7.4, 50 mM KCl, 10% glycerol, 0.1 mg/ml sheared salmon sperm DNA, 10 mM melibiose, 1 mM EDTA, and 1 mM dithiothreitol. After incubation for 5 min at 37 °C, samples were applied to 5% polyacrylamide gels that were run in standard Tris-borate/EDTA electrophoresis buffer at 150 V. After electrophoresis, gels were fixed, dried, and exposed to x-ray film. Gel retardation assays were also performed with the shorter ET2 and ET3 probes illustrated in Fig. 1. These probes were made by annealing the appropriate complementary oligos after 5'-end labeling with 32P using T4 polynucleotide kinase.

DNase I Footprinting Experiments-- These experiments were performed with EcoRI-HindIII fragments carrying the wild type or mutant mel operon regulatory region using previously described protocols (16). Incubations contained 4-10 nM of the purified fragment that had been specifically radiolabeled at the HindIII end using [gamma -32P]ATP and polynucleotide kinase, and different amounts of purified His-tagged MelR and melibiose as indicated. After DNase I treatment, footprint patterns were analyzed on polyacrylamide sequencing gels that were calibrated with Maxam-Gilbert sequence ladders.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In Vivo Assays with the W3133-2 Mutant melABPromoter-- In our previous work, we described the W3133-2 mutant that results from five consecutive base changes in the melAB promoter (7). To study the effects of these changes in vitro, we subcloned EcoRI-HindIII DNA fragments carrying the wild type or W3133-2 mutant melAB promoter sequences (Fig. 1). First, using PCR, we amplified the KK81 fragment that carries the entire melAB promoter with all four MelR binding sites (sites 1', 1, 2, and 2') that are known to be essential for optimal melAB promoter activity (10, 11). Second, we amplified the shorter JK14 fragment that carries the melAB transcript start site and only the MelR binding sites 2 and 2'. In preliminary experiments, we checked the activity of the melAB promoter carried by these fragments. To do this, the different EcoRI-HindIII fragments were cloned into the broad host range lac fusion vector, pRW50, and the resulting plasmids were transformed into WAM131, a Delta lac mel+ strain derived from GM-1 (11, 14). Expression of the promoter melAB::lacZ fusions carried by the pRW50 recombinants was measured in transformants grown either with or without the inducer, melibiose. The results, listed in Table I, indicate that, with the longer KK81 fragment, expression from the melAB promoter is clearly induced by melibiose and that the W3133-2 mutant promoter is 8- to 9-fold more active than the wild type promoter. With the shorter JK14 fragment, the removal of MelR binding sites 1' and 1 results in a 4-fold reduction in expression of the melAB promoter. However, in contrast, with the W3133-2 mutant, melAB promoter activity is only slightly affected by removal of MelR binding sites 1' and 1. Thus, the base changes in the W3133-2 mutant result in a >20-fold increase in melAB promoter activity in the context of the shorter JK14 fragment. These results show that the effects of the base changes in the W3133-2 mutant are easily detected in short fragments and encouraged us to attempt in vivo studies.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   The E. coli mel operon regulatory region. A, a diagram of the intercistronic region between the divergently transcribed melA and melR genes: horizontal arrows indicate the corresponding transcription start sites. DNA sequences are numbered with respect to the melAB transcript start as +1. The melAB promoter -10 and -35 hexamers are indicated by open rectangles. The figure illustrates the KK81 fragment bounded by an upstream EcoRI site at position -312 and a downstream HindIII site at position +36, and the JK14 fragment bounded by an upstream EcoRI site at position -94 and a downstream HindIII site at position +36. The locations of the DNA sites for MelR are indicated by triangles: each triangle indicates an 18-base pair sequence and its orientation, and the position of the center of each site is denoted. Filled triangles, sites 1 and 2, which have identical sequences; gray triangles, site 1' and the related site R that overlaps the melR promoter; open triangle, weak site 2' that is discussed here. The locations of the -160 and -10 primers, which were used to generate ET1 probes for the gel retardation assays are shown. B, shows the DNA sequence around MelR binding sites (sites 1', 1, 2, and 2') in the wild type melAB promoter and in the W3133-2 mutant. The consecutive five-nucleotide mutation is shown with bold letters. The underlined sequences between sites 1' and 2, and those between sites 1 and 2', are identical. The location of the ET2 and ET3 probes used in the gel retardation assays are also indicated.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Transcription activation of the melAB promoter
beta -Galactosidase activities (in Miller units) were measured in WAM131 cells containing pRW50 carrying the KK81 or JK14 fragments with the wild type or W3133-2 mutant melAB promoter sequences. The measured activities are indicative of the expression of melAB promoter::lac fusions carried by the pRW50 derivatives. Cells were grown in minimal media with fructose as a carbon source either with or without melibiose exactly as in our previous work (5). Data shown are the average values from three independent experiments.

Overexpression and Purification of His-tagged MelR-- To perform in vitro study, we needed to purify MelR. However, the published method for purification of MelR required a large amount of medium and a complicated column works (20). Therefore, we employed Ni2+ affinity chromatography for the purification and T7 expression system for overexpression of MelR. First we constructed a plasmid that carries a derivative melR encoding MelR with the carboxyl-terminal hexahistidine tag (MelRH). The derivative melR gene is located downstream from the T7 promoter. To confirm that the MelRH is functional in vivo, a XbaI-EcoRI fragment, which carries a Shine-Dalgarno sequence was subcloned from pETRH or pETR into pMW119, in which expression of melRH or melR is controlled by the lac promoter. A MelR-defective mutant, Y1089 (Delta melR) (19), harboring either one of the constructed plasmids, formed similar red colonies on a MacConkey-melibiose (5 mM) plate (data not shown). This result indicates that the MelRH worked as a transcription activator for the melibiose operon in vivo. Other results from gel retardation assay and in vitro transcription assay done with MelR or MelRH indicated that MelRH had almost the same DNA binding affinity and transcription activation activity as wild type MelR (data not shown).

For overexpression of MelRH, we used the T7 system. We tested several media and found that M9 medium increased the expression level of our target protein and reduced background proteins. The MelRH protein produced in BL21(DE3)/pETRH after addition of isopropyl beta -D-thiogalactopyranoside reached about 10-20% of total cell protein. However, most of the overproduced MelRH protein formed inclusion body. The advantage of this preparation was that the MelRH in the inclusion body was more than 80% pure without any column works. The inclusion body was solubilized with 6 M guanidine buffer and purified using Ni2+-agarose. The purified protein was renatured by dialysis and then concentrated by ultrafiltration. When concentration of the purified MelRH was high, precipitation occurred during dialysis and most protein bound to filter during ultrafiltration. Our protocol yielded 500 µg of >= 95% pure His-tagged MelR from 200 ml of culture. This amount is enough for in vitro analysis. The renatured MelRH showed almost identical transcription activation activity as that observed with MelR purified by the method reported previously (19) without denaturation (data not shown).

Activation of the melAB Promoter in Vitro using Purified MelR-- It is important to test whether the results obtained in the in vivo system (Table I and Ref. 7) are reproducible in the in vitro system. To do this, we cloned EcoRI-HindIII DNA fragments carrying the wild type or W3133-2 mutant melAB promoter sequences into the pSR vector plasmid, which carries the bacteriophage lambda  oop transcription terminator just downstream of the HindIII site (12). The resulting recombinant plasmids were used to monitor MelR-dependent activation at the melAB promoter; i.e. transcripts initiating at the melAB promoter run to the lambda  oop terminator and give discrete transcripts that are easy to detect by gel electrophoresis. In addition, because pSR contains a ColE1 replication origin, the RNA I transcript can be used as an internal control to aid quantification of MelR-dependent transcripts. Fig. 2 shows the results from a typical experiment, where purified RNAP, together with purified MelR and melibiose, was preincubated with purified circular pSR plasmid carrying the JK14 or KK81 insert, prior to the addition of labeled nucleoside triphosphates. Each incubation produces the control RNA I transcript, but a longer transcript originating at the melAB transcript start is seen when the preincubation includes purified MelR and melibiose. With both the JK14 and KK81 inserts, more transcript initiating at the melAB promoter is observed with template from the W3133-2 mutant. We have done three sets of the same experiment and two sets of an experiment in which concentration of RNA polymerase was increased to 150 nM. All of the results were almost identical to the result in Fig. 2. From these experiments, we conclude that the effects of the base changes in the W3133-2 mutant can be reproduced, at least partially, in vitro.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 2.   In vitro transcription initiation at the melAB promoter. The figure shows autoradiographs of gels on which RNA synthesized in vitro by E. coli RNAP was analyzed. The template is the pSR plasmid carrying the KK81 or JK14 inserts carrying the wild type or W3133-2 mutant melAB promoter sequences. The locations of the "constitutive" RNA I transcript and the transcript starting at the melAB promoter are indicated. The preincubations contained melibiose (10 mM) and different concentrations of purified MelR as indicated. The lower part shows quantification of the transcript starting at the melAB promoter in the different experiments relative to the RNA I transcript.

Gel Retardation Assays-- It had previously been noted that the base changes in the melAB promoter in the W3133-2 mutant changed the DNA sequence of MelR binding site 2' such that it corresponded better to the tighter binding sites 1', 1, and 2. Therefore, gel retardation assays were used to measure the binding of purified MelR to the different sites at the wild type or W3133-2 mutant melAB promoter. In the first experiment (Fig. 3A), we measured the binding of MelR to ET1 fragments carrying MelR binding sites 1', 1, 2, and 2' (the ET1 fragments were made using PCR with the -160 and -10 primers and pBM3133 or pBM3133-2 as templates: see Fig. 1). With the wild type ET1 fragment, four retarded bands are observed, with the most retarded bands appearing at higher MelR concentrations. We attribute these bands to progressive occupation of the four DNA sites for MelR: as expected, the fourth, most retarded band remained quite weak, in agreement with our previous observation that MelR binds weakly to site 2'. However, with the ET1 fragment from the W3133-2 mutant, this fourth retarded band appears much stronger, suggesting that the base changes in the mutant have tightened the binding of MelR to site 2'. The second experiment (Fig. 3B) with the shorter ET2 fragment, carrying only MelR binding sites 2 and 2', confirmed this interpretation: with the fragment derived from the wild type melAB promoter, two retarded bands are observed, with only a small amount of the more retarded band appearing at higher MelR concentrations. However, with the ET2 fragment from the W3133-2 mutant, this second more retarded band appears much stronger. Finally, the control experiment (Fig. 3C) with the ET3 fragment carrying only MelR binding site 2 shows just one retarded band that is unaffected by the base changes from the W3133-2 mutant. Note that the version of this fragment derived from the mutant does contain the five base changes (see Fig. 1), but these do not affect MelR binding to site 2. It should also be noted that MelR did not bind to the fragment carrying just site 2' (data not shown).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Gel retardation studies. Autoradiographs of gel retardation experiments to measure the binding of purified MelR to different DNA fragments. A, binding to ET1 probes carrying MelR binding sites 1', 1, 2, and 2' from the wild type or W3133-2 mutant melAB promoter. B and C, binding to the ET2 or ET3 probes from the wild type or W3133-2 mutant melAB promoter. The quantities of MelR used in each incubation are indicated.

DNase I Footprinting Experiments-- To confirm the conclusions from gel retardation assays, we used DNase I footprinting to study the binding of purified MelR to the JK14 fragment carrying the wild type or W3133-2 mutant melAB promoter sequences. The results (Fig. 4) show that, with the wild type melAB promoter sequence, MelR affords clear protection of the segment of DNA corresponding to MelR binding site 2. However, even in the presence of melibiose and higher concentrations of MelR, very poor protection of the segment of DNA corresponding to MelR binding site 2' is observed. However, with the JK14 fragment derived from the W3133-2 mutant, clear protection of both site 2 and site 2' is seen, even in the absence of melibiose.


View larger version (128K):
[in this window]
[in a new window]
 
Fig. 4.   DNase I footprint analysis of MelR binding. An autoradiograph of a sequencing gel run to analyze products after DNase I cleavage of complexes formed by MelR at the JK14 fragment from the wild type or W3133-2 mutant melAB promoter. The quantities of MelR used in each incubation are indicated. Maxam-Gilbert sequencing reactions were used to calibrate the gel. The calibration that is shown takes the melAB transcript start point as +1, and the vertical bars indicate the locations of MelR binding sites 2 and 2'.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

From our results, we conclude that, as predicted, the five base changes in the melAB promoter of the W3133-2 mutant improve the binding of MelR to site 2'. We suppose that this improvement in MelR binding is responsible for the increased melAB promoter activity in the W3133-2 mutant, although we cannot prove that it is solely responsible. In our previous paper, we noted that the five base changes in the W3133-2 mutant create an extended 28-nucleotide inverted repeat at the melAB promoter (7). We suggested that this inverted repeat might facilitate the formation of a stem-loop structure and that this may be responsible for the increased melAB promoter activity in the W3133-2 mutant. However, our observation that the increased melAB promoter activity is observed even in the absence of MelR binding sites 1' and 1 (i.e. with the JK14 fragment, which lacks the extended inverted repeat) proves that this cannot be the case. Indeed, the effects of the five base changes are greater with the JK14 fragment: this appears to be because MelR binding to site 2' is aided by MelR binding to sites 1' and 1, and thus, in the absence of sites 1 and 1', improvement of site 2' has a proportionately greater effect.

Taken together, our results show that the activity of the melAB promoter is limited by the binding of MelR to site 2'. Because this site overlaps the -35 hexamer of the melAB promoter, it appears that MelR, like AraC and many other members of the AraC family, may be a typical "Class II" transcription activator (17). Our results suggest that the principal function of the upstream sites 1' and 1 is to help the occupation of site 2'. Thus, the requirement of sites 1' and 1 for melAB promoter activity is greatly reduced when MelR binding site 2' is improved (Table I). It is known that Class II transcription activators function by making a direct contact with Region 4 of the RNAP sigma  subunit (18). Thus, the challenge now is to understand the molecular details of the MelR-sigma subunit interactions.

    ACKNOWLEDGEMENTS

We thank Victoria Howard, Eva Hyde, and Joseph Wade of The University of Birmingham for many helpful discussions.

    FOOTNOTES

* This work was supported by grants from the Ministry of Education, Science and Culture of Japan and from the United Kingdom Biotechnology and Biological Sciences Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, 700-8530 Japan. Tel./Fax: 81-86-251-7957; E-mail: tsuchiya@pheasant.pharm.okayama-u.ac.jp.

Published, JBC Papers in Press, March 21, 2000, DOI 10.1074/jbc.M000499200

2 E. Tamai, unpublished data.

    ABBREVIATIONS

The abbreviations used are: RNAP, RNA polymerase holoenzyme; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Prestidge, L., and Pardee, A. (1965) Biochim. Biophys. Acta 100, 591-593
2. Schmitt, R. (1968) J. Bacteriol. 96, 462-471
3. Levinthal, M. (1971) J. Bacteriol. 105, 1047-1052
4. Hanatani, M., Yazyu, H., Shiota-Niiya, S., Moriyama, Y., Kanazawa, H., Futai, M., and Tsuchiya, T. (1984) J. Biol. Chem. 259, 1807-1812
5. Webster, C., Kempsell, K., Booth, I., and Busby, S. (1987) Gene 59, 253-263
6. Tsuchiya, T., Lopilato, J., and Wilson, T. (1976) J. Membr. Biol. 42, 45-59
7. Tamai, E., Shimamoto, T., Tsuda, M., Mizushima, T., and Tsuchiya, T. (1998) J. Biol. Chem. 273, 16860-16864
8. Webster, C., Gardner, L., and Busby, S. (1989) Gene 83, 207-213
9. Webster, C., Gaston, K., and Busby, S. (1988) Gene 68, 297-305
10. Williams, J., Michán, C., Webster, C., and Busby, S. (1994) Biochem. J. 300, 757-763
11. Belyaeva, T., Wade, J., Webster, C., Howard, V., Thomas, M., Hyde, E., and Busby, S. (2000) Mol. Microbiol. 36, 211-222
12. Kolb, A., Kotlarz, D., Kusano, S., and Ishihama, A. (1995) Nucleic Acids Res. 23, 819-826
13. Lodge, J., Fear, J., Busby, S., Gunaseker, P., and Kamini, N-R. (1992) FEMS Microbiol. Lett. 95, 271-276
14. Coulondre, C., and Miller, J. (1977) J. Mol. Biol. 117, 525-575
15. Miller, J. (1972) Experiments in Molecular Genetics , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
16. Savery, N., Belyaeva, T., and Busby, S. (1996) Essential Techniques: Gene Transcription (Docherty, K., ed) pp. 1-5, 21-33, BIOS Scientific Publishers, Oxford
17. Gallegos, M.-T., Schleif, R., Bairoch, A., Hofmann, K., and Ramos, J.-L. (1997) Microbiol. Mol. Biol. Rev. 61, 393-410
18. Rhodius, V., and Busby, S. (1998) Curr. Opin. Microbiol. 1, 152-159
19. Bourgerie, S., Michán, C., Thomas, M., Busby, S., and Hyde, E. (1997) Nucleic Acids Res. 25, 1685-1693
20. Caswell, R., Williams, J., Lyddiatt, A., and Busby, S. (1992) Biochem. J. 287, 493-499


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
J. A. Ibarra, M. I. Villalba, and J. L. Puente
Identification of the DNA Binding Sites of PerA, the Transcriptional Activator of the bfp and per Operons in Enteropathogenic Escherichia coli
J. Bacteriol., May 1, 2003; 185(9): 2835 - 2847.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. Peralta-Gil, D. Segura, J. Guzman, L. Servin-Gonzalez, and G. Espin
Expression of the Azotobacter vinelandii Poly-{beta}-Hydroxybutyrate Biosynthetic phbBAC Operon Is Driven by Two Overlapping Promoters and Is Dependent on the Transcriptional Activator PhbR
J. Bacteriol., October 15, 2002; 184(20): 5672 - 5677.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. J. Howard, T. A. Belyaeva, S. J. W. Busby, and E. I. Hyde
DNA binding of the transcription activator protein MelR from Escherichia coli and its C-terminal domain
Nucleic Acids Res., June 15, 2002; 30(12): 2692 - 2700.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/22/17058    most recent
M000499200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamai, E.
Right arrow Articles by Tsuchiya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamai, E.
Right arrow Articles by Tsuchiya, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.